104.04  0.31 (0.3%)		04-14 16:00
Open: 103.39 High: 104.635 Volume: 151,970		Pre. Close: 103.73 Low: 103.39 Market Cap: 614(M)

Short term
Mid term
Targets	6-month :	125.46	1-year :	146.54
Resists	First :	107.41	Second :	125.46
Pivot price	103.23
Supports	First :	102.95	Second :	100.19
MAs	MA(5) :	104.27	MA(20) :	102.93
	MA(100) :	104.65	MA(250) :	94.7
MACD	MACD :	-0.5	Signal :	-0.9
%K %D	K(14,3) :	69.3	D(3) :	74.8
RSI	RSI(14): 49.4
52-week	High :	112.58	Low :	80.6

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ PPH ] has closed below upper band by 32.1%. Bollinger Bands are 22.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	104.08 - 104.78	104.78 - 105.36
Low:	101.48 - 102.17	102.17 - 102.74
Close:	102.72 - 103.84	103.84 - 104.77

VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Thu, 02 Apr 2026
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance

Wed, 01 Apr 2026
VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.8441 - MSN

Mon, 30 Mar 2026
Healthcare ETFs in Spotlight Amid Eli Lily's $2.8B AI Drug Move - TradingView — Track All Markets

Sat, 28 Mar 2026
PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026 - AOL.com

Sat, 28 Mar 2026
PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026 - 24/7 Wall St.

Mon, 02 Mar 2026
PPH, IHE, PJP: U.S. Pharmaceutical ETFs Offer Investors Innovation and Growth - TipRanks

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.